TITLE

Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred

AUTHOR(S)
Takada, Daisuke; Emi, Mitsuru; Ezura, Yoichi; Nobe, Yukiko; Kawamura, Katsumi; Iino, Yasuhiko; Katayama, Yasuo; Yuanpei Xin; Wu, Lily L.; Larringa-Shum, Stacey; Stephenson, Susan H.; Hunt, Steven C.; Hopkins, Paul N.
PUB. DATE
December 2002
SOURCE
Journal of Human Genetics;2002, Vol. 47 Issue 12, p656
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Lipid and lipoprotein concentrations in plasma generally reflect complex influences of multiple genetic loci. Even an autosomal dominant disorder, familial hypercholesterolemia (FH), is characterized by phenotypic heterogeneity, as low-density lipoprotein (LDL) levels vary widely within the same pedigree. Molecular screening for LDL receptor (LDLR) mutations among 75 patients with clinically apparent FH led to identification of a novel splice-site mutation (IVS14 + 1 G > A) shared by 14 patients. Genealogical research confirmed that all 14 carriers were part of the same l135-member pedigree with a common ancestor. The mutation resulted in an abruptly truncated LDLR protein, reducing functional LDLR activity by half in heterozygous carriers of the mutant allele. Of the 208 members of the kindred who were screened for the presence of this LDLR mutation, we identified 94 carriers and 114 noncarriers. Nine principal apolipoprotein genes that might affect LDL cholesterol differentially according to LDLreceptor status were examined in this pedigree. Strikingly lower total cholesterol and LDL-cholesterol values were observed among the majority of the LDLR mutation carriers who were simultaneously homozygous for the -265C variant of apoA-II (total cholesterol: 324 ± 8 vs 244 ± 19 mg/dl, P = 0.0015; LDL-cholesterol: 237 ± 8 vs 155 ± 18 mg/dl, P = 0.0008). In vitro transfection assays showed that transcriptional activity of the apoA-II promoter was reduced by 30% in the -265C variant as compared with the -265T variant. We thus concluded that one variant of the apoA-II gene was associated with reduced plasma LDL cholesterol only in FH patients.
ACCESSION #
9338749

 

Related Articles

  • Familial defective apolipoprotein B-100 in a group of hypercholesterolaemic patients in Poland. Identification of a new mutation Thr3492Ile in the apolipoprotein B gene. Bednarska-Makaruk, Małgorzata; Bisko, Mariola; Puławska, Maria F; Hoffman-Zacharska, Dorota; Rodo, Maria; Roszczynko, Marta; Solik-Tomassi, Alicja; Broda, Grażyna; Polakowska, Maria; Pytlak, Aleksandra; Wehr, Hanna // European Journal of Human Genetics;Nov2001, Vol. 9 Issue 11, p836 

    The prevalence of the familial defective apolipoprotein B-100 (FDB) Arg[sub 3500]Gln mutation in 525 unrelated hypercholesterolaemic Polish subjects was evaluated. DNA samples were screened for FDB mutation using SSCP method. Presence of mutation was confirmed using a mismatch Mspl PCR strategy....

  • Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia. Futema, Marta; Plagnol, Vincent; Whittall, Ros A.; Neil, H. Andrew W.; Humphries, Steve Eric // Journal of Medical Genetics;Oct2012, Vol. 49 Issue 10, p644 

    Background Familial Hypercholesterolaemia (FH) is an autosomal dominant disease, caused by mutations in LDLR, APOB or PCSK9, which results in high levels of LDL-cholesterol (LDL-C) leading to early coronary heart disease. An autosomal recessive form of FH is also known, due to homozygous...

  • Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy. Takane, Hiroshi; Miyata, Masanori; Burioka, Naoto; Shigemasa, Chiaki; Shimizu, Eiji; Otsubo, Kenji; Ieiri, Ichiro // Journal of Human Genetics;Sep2006, Vol. 51 Issue 9, p822 

    Pravastatin is mainly taken up from the circulation into the liver via organic anion-transporting polypeptide 1B1 ( SLCO1B1 gene product). We examined the contribution of genetic variants in the SLCO1B1 gene and other candidate genes to the variability of pravastatin efficacy in 33...

  • Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL–C levels in a latvian population. Radovica-Spalvina, Ilze; Latkovskis, Gustavs; Silamikelis, Ivars; Fridmanis, Davids; Elbere, Ilze; Ventins, Karlis; Ozola, Guna; Erglis, Andrejs; Klovins, Janis // BMC Medical Genetics;9/29/2015, Vol. 16 Issue 1, p1 

    Background: Familial hypercholesterolemia (FH) is one of the commonest monogenic disorders, predominantly inherited as an autosomal dominant trait. When untreated, it results in early coronary heart disease. The vast majority of FH remains undiagnosed in Latvia. The identification and early...

  • Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach. Versmissen, Jorie; Oosterveer, Daniëlla M; Yazdanpanah, Mojgan; Dehghan, Abbas; Hólm, Hilma; Erdman, Jeanette; Aulchenko, Yurii S; Thorleifsson, Gudmar; Schunkert, Heribert; Huijgen, Roeland; Vongpromek, Ranitha; Uitterlinden, André G; Defesche, Joep C; van Duijn, Cornelia M; Mulder, Monique; Dadd, Tony; Karlsson, Hróbjartur D; Ordovas, Jose; Kindt, Iris; Jarman, Amelia // European Journal of Human Genetics;Mar2015, Vol. 23 Issue 3, p381 

    Mutations in the low-density lipoprotein receptor (LDLR) gene cause familial hypercholesterolemia (FH), a disorder characterized by coronary heart disease (CHD) at young age. We aimed to apply an extreme sampling method to enhance the statistical power to identify novel genetic risk variants for...

  • The distribution and characteristics of LDL receptor mutations in China: A systematic review. Jiang, Long; Sun, Li-Yuan; Dai, Yan-Fang; Yang, Shi-Wei; Zhang, Feng; Wang, Lu-Ya // Scientific Reports;11/27/2015, p17272 

    Familial hypercholesterolemia (FH) is a common and serious dominant genetic disease, and its main pathogenic gene is the low-density lipoprotein receptor (LDLR) gene. This study aimed to perform a systematic review of LDLR mutations in China. Using PubMed, Embase, Wanfang (Chinese), the Chinese...

  • Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosis. Ishii, J.; Nagano, M.; Kujiraoka, T.; Ishihara, M.; Egashira, T.; Takada, D.; Tsuji, M.; Hattori, H.; Emi, M. // Journal of Human Genetics;2002, Vol. 47 Issue 7, p366 

    Despite progress in molecular characterization, specific diagnoses of disorders belonging to a group of in-herited hypoalphalipoproteinemias, i.e., apolipoprotein AI deficiency, lecithin-cholesterol acyltransferase deficiency, Tangier disease (TD), and familial high-density lipoprotein (HDL)...

  • The effects of problem content and scientific background on information search and the assessment and valuation of correlations. Soffer, Shira; Kareev, Yaakov // Memory & Cognition;Jan2011, Vol. 39 Issue 1, p107 

    The effects of problem contents and one's scientific background on the detection of correlations and the assessment of their strength were studied using a task that required active data search, assessment of the strength of a correlation, and monetary valuation of the correlation's predictive...

  • Deadly family trees. Rubin, Rita // U.S. News & World Report;1/24/94, Vol. 116 Issue 3, p71 

    Focuses on a new project that tracks a high-cholesterol gene that kills early. Disorder called familial hypercholesterolemia, or FH, which causes sky-high levels of cholesterol in the blood; Chances for passing FH on to offsprings; Efforts of Roger Williams, a professor of internal medicine, to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics